» Articles » PMID: 11668190

Immunocytochemical Analysis of Cell Lines Derived from Solid Tumors

Overview
Publisher Sage Publications
Specialty Biochemistry
Date 2001 Oct 23
PMID 11668190
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Antibodies recognizing tissue-specific antigens are widely used to identify the histological origin of tumors. Here we tested the fidelity of selected tissue markers on all 167 solid tumor-derived continuous cell lines in the DSMZ cell lines bank. Most lines had an intermediate filament content consistent with the tumor type from which they were derived. Thus, 93% of all carcinoma cell lines expressed keratin filaments. With certain antibodies, some subclassification was possible. For example, the CK7 keratin 7 antibody can differentiate between colon and pancreas-derived carcinoma cell lines. Cell lines derived from non-carcinomas, in general, did not express keratin but were vimentin-positive. Four of 10 glioma/astrocytoma cell lines expressed GFAP, five of six neuroblastoma cell lines expressed neurofilaments, and the TE-671 rhabdomyosarcoma cell line expressed desmin. When other tissue markers were tested, 12/16 melanoma-derived cell lines expressed HMB-45, while PSA, CA125, and thyroglobulin were less useful. These results demonstrate that cell lines retain some but not all markers typical of the original tumor type and identify certain markers useful in characterizing the histological origin of cell lines. Our data question the identity of some cell lines submitted to the bank in the past. The immunoprofiles of 167 solid tumor-derived and 131 hematopoetic cell lines can be found at www.dsmz.de.

Citing Articles

Plasma Rich in Growth Factors in Bone Regeneration: The Proximity to the Clot as a Differential Factor in Osteoblast Cell Behaviour.

Anitua E, Zalduendo M, Tierno R, Alkhraisat M Dent J (Basel). 2024; 12(5).

PMID: 38786520 PMC: 11119057. DOI: 10.3390/dj12050122.


Co-dependent regulation of p-BRAF and potassium channel KCNMA1 levels drives glioma progression.

Xie S, Xu C, Wu C, Lou Y, Duan J, Sang R Cell Mol Life Sci. 2023; 80(3):61.

PMID: 36763212 PMC: 9918570. DOI: 10.1007/s00018-023-04708-9.


Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx Digital Spatial Profiler.

Hernandez S, Lazcano R, Serrano A, Powell S, Kostousov L, Mehta J Front Oncol. 2022; 12:890410.

PMID: 35847846 PMC: 9277770. DOI: 10.3389/fonc.2022.890410.


MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and experiments.

Li M, Zhou L, Li S, Fang L, Yang L, Wu X Oncol Lett. 2021; 22(1):536.

PMID: 34084216 PMC: 8161407. DOI: 10.3892/ol.2021.12797.


ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line.

Chen Y, Liu K, Jang C, Hsu C, Yen Y, Liu Y Cancers (Basel). 2019; 12(1).

PMID: 31878324 PMC: 7016611. DOI: 10.3390/cancers12010061.